Anti-PD-1 Monoclonal Antibody
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Anti-PD-1 Monoclonal Antibody, covering 2019-02-15 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer [EARLY_Phase 1]